Pfizer
News About Pfizer

San Diego’s Life Sciences Activity Mixed in 2024, Including With Some Optimism
By Nick Trombola
Premium






Top U.S. Lab REIT Unloaded $1.3B in 2023 While Portfolio Lost $460M in Value
By Greg Cornfield
Premium




Oxford Properties Buys Life Science Assets From Carlyle Group, King Street for $151M
By Cathy Cunningham
Premium

Sun Belt, Mountain West Emerge As U.S. Investor Safe Havens During COVID
By Rebecca Baird-Remba
Premium


